NCT00617396 - Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

May 31, 2012

Conditions

Functional Bowel Disorders

Interventions

DRUG

Quetiapine (50 mg/day-100mg/day)

Subject begin with a dose quetiapine of 50mg for 2 weeks, increasing to 100mgs for the remainder of the study. (8 weeks total)

Trial Locations (1)

UNC Center for Functional GI & Motility Disorders, Chapel Hill